Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Oric Pharmaceuticals Inc (ORIC)

Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Thu Jul 3, 3:30PM CDT

ORIC : 11.10 (-3.06%)
New Wave of Cancer Treatments Could Change the Game for Patients - and Investors BayStreet.ca - Tue Jun 24, 10:15AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The rising burden of cancer is poised to strain both healthcare systems and patient finances, especially...

ONCY : 1.1800 (+5.83%)
NRIX : 12.44 (-1.82%)
ORIC : 11.10 (-3.06%)
EXEL : 44.86 (-0.69%)
YMAB : 4.36 (-3.54%)
ONC.TO : 1.60 (+5.96%)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Jun 6, 3:30PM CDT

ORIC : 11.10 (-3.06%)
ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC GlobeNewswire - Wed May 28, 3:05PM CDT

ORIC : 11.10 (-3.06%)
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing GlobeNewswire - Wed May 28, 3:05PM CDT

ORIC : 11.10 (-3.06%)
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire - Tue May 27, 3:30PM CDT

ORIC : 11.10 (-3.06%)
ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC GlobeNewswire - Tue May 27, 7:00AM CDT

ORIC : 11.10 (-3.06%)
ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates GlobeNewswire - Mon May 5, 3:05PM CDT

ORIC : 11.10 (-3.06%)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri May 2, 3:30PM CDT

ORIC : 11.10 (-3.06%)
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire - Mon Apr 28, 3:30PM CDT

ORIC : 11.10 (-3.06%)

Barchart Exclusives

Tariffs, Inflation and Other Key Things to Watch this Week Barchart - Sun Jul 13, 12:00PM CDT
Markets enter the heart of earnings season with the S&P 500 facing a critical test as major financial institutions kick off quarterly results amid escalating trade tensions. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot